- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/565 - IFN-beta
Patent holdings for IPC class C07K 14/565
Total number of patents in this class: 245
10-year publication summary
|
28
|
31
|
15
|
14
|
26
|
20
|
20
|
19
|
21
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19868 |
12 |
| Orionis Biosciences BV | 84 |
11 |
| Abion Inc. | 66 |
10 |
| Modernatx, Inc. | 1256 |
10 |
| Orionis Biosciences Inc. | 96 |
10 |
| Biogen MA Inc. | 893 |
7 |
| East Carolina University | 182 |
7 |
| Ubiprotein, Corp. | 11 |
7 |
| Mayo Foundation for Medical Education and Research | 3201 |
6 |
| Ares Trading S.A. | 299 |
6 |
| Faron Pharmaceuticals Oy | 89 |
6 |
| Glytech, Inc. | 65 |
6 |
| Universiteit Gent | 1329 |
6 |
| Vib VZW | 867 |
6 |
| CytomX Therapeutics, Inc. | 220 |
5 |
| Rutgers, The State University of New Jersey | 1890 |
5 |
| The Brigham and Women's Hospital, Inc. | 2179 |
4 |
| Immunwork Inc. | 25 |
4 |
| Synairgen Research Limited | 9 |
4 |
| Idemitsu Kosan Co., Ltd. | 4212 |
3 |
| Other owners | 110 |